Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.15
$0.081.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -173.97% | -94.27% | -100.84% | -223.21% | -170.05% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,161.42% | 2,328.82% | -53.86% | -44.21% | 69.79% |
| Change in Net Operating Assets | 53.08% | -11.72% | 648.46% | 306.41% | -279.38% |
| Cash from Operations | -34.86% | -200.17% | -48.34% | -228.40% | -199.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 99.94% | -62.76% | 20.10% | 20.29% |
| Issuance of Common Stock | 34,600.00% | -- | -- | -100.00% | -99.99% |
| Repurchase of Common Stock | -- | -606.26% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 189.84% | 606.76% | 20.52% | -- | 2,934.39% |
| Cash from Financing | 197.40% | 138.49% | 53,815.24% | -34.53% | -43.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 501.96% | -156.38% | 4,048.10% | -209.95% | -77.57% |